MISONIX, Inc. (MSON): Price and Financial Metrics

MISONIX, Inc. (MSON): $18.33

-0.48 (-2.55%)

POWR Rating

Component Grades














  • Sentiment is the dimension where MSON ranks best; there it ranks ahead of 95.74% of US stocks.
  • MSON's strongest trending metric is Sentiment; it's been moving up over the last 200 days.
  • MSON's current lowest rank is in the Momentum metric (where it is better than 15.17% of US stocks).

MSON Stock Summary

  • Misonix Inc's stock had its IPO on March 25, 1993, making it an older stock than 78.19% of US equities in our set.
  • Of note is the ratio of Misonix Inc's sales and general administrative expense to its total operating expenses; 76.7% of US stocks have a lower such ratio.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.4 for Misonix Inc; that's greater than it is for just 20.35% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Misonix Inc are SXI, PESI, MYE, ROAD, and EVI.
  • Visit MSON's SEC page to see the company's official filings. To visit the company's web site, go to www.misonix.com.

MSON Price Target

For more insight on analysts targets of MSON, see our MSON price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $23.00 Average Broker Recommendation 1.17 (Strong Buy)

MSON Stock Price Chart Interactive Chart >

Price chart for MSON

MSON Price/Volume Stats

Current price $18.33 52-week high $20.71
Prev. close $18.81 52-week low $9.06
Day low $18.30 Volume 33,400
Day high $18.78 Avg. volume 55,061
50-day MA $19.24 Dividend yield N/A
200-day MA $14.88 Market Cap 319.07M

MISONIX, Inc. (MSON) Company Bio

Misonix, Inc. produces and distributes medical devices. The Company offers devices for spinal decompression, wound management, tumor removal, and general surgery. Misonix markets its products in the United States.

MSON Latest News Stream

Event/Time News Detail
Loading, please wait...

MSON Latest Social Stream

Loading social stream, please wait...

View Full MSON Social Stream

Latest MSON News From Around the Web

Below are the latest news stories about Misonix Inc that investors may wish to consider to help them evaluate MSON as an investment opportunity.

Misonix, Inc. (MSON) CEO Stavros Vizirgianakis on Q3 2021 Results - Earnings Call Transcript

Misonix, Inc. (MSON) Q3 2021 Earnings Conference Call May 06, 2021, 16:30 ET Company Participants Norberto Aja - JCIR Stavros Vizirgianakis - CEO & Director Joseph Dwyer - CFO, Treasurer & Secretary Conference Call Participants Alexander Nowak - Craig-Hallum Ryan Zimmerman - BTIG Presentation Operator Good day, and welcome to...

SA Transcripts on Seeking Alpha | May 9, 2021

Misonix Reports Fiscal 2021 Third Quarter Financial Results

Misonix Raises Guidance for neXus® Ultrasonic Surgical System to 200 Unit Placements by Fiscal 2021 Year-EndFARMINGDALE, N.Y., May 06, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today reported financial results for the fiscal 2021 third quarter ended March 31, 2021 as summarized below: Three Months Ended Nine Months Ended March 31, March 31, 2021 2020 2021 2020 Revenue$18,347,180 $17,902,512 $54,338,932 $48,770,419 Gross profit$12,944,426 $12,590,947 $38,560,879 $34,277,098 Gross profit percentage 70.6% 70.3% 71.0% 70.3%Pretax loss$(3,756,804) $(6,043,477) $(10,000,053) $(13,420,961)Income tax benefit$- $(455,000) $- $...

Yahoo | May 6, 2021

Misonix, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 6, 2021 / Misonix, Inc. (NASDAQ:MSON) will be discussing their earnings results in their 2021 Third Quarter Earnings call to be held on May 6, 2021 at 4:30 PM Eastern Time.

Yahoo | May 6, 2021

Did You Miss Misonix's (NASDAQ:MSON) Impressive 264% Share Price Gain?

When you buy a stock there is always a possibility that it could drop 100%. But when you pick a company that is really...

Yahoo | May 3, 2021

Misonix Receives Health Canada Approval for neXus

FARMINGDALE, N.Y., March 04, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that it has received a Health Canada license for the neXus® Ultrasonic Surgical System. This approval confirms that neXus meets the requirements of Health Canada, allowing Misonix to commercialize neXus, along with its various handpieces and disposable products, across Canada. Stavros Vizirgianakis, President and Chief Executive Officer of Misonix stated, “We are very pleased Health Canada has approved the use of neXus. This approval, along with our CE Mark certification, is further affirmation of our technology, and allows us to co...

Yahoo | March 4, 2021

Read More 'MSON' Stories Here

MSON Price Returns

1-mo -7.94%
3-mo 4.62%
6-mo 47.58%
1-year 81.67%
3-year 56.67%
5-year 337.47%
YTD 46.64%
2020 -32.83%
2019 16.24%
2018 69.42%
2017 -9.57%
2016 11.17%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.7741 seconds.